Copyright Reports & Markets. All rights reserved.

Global Radiopharmaceutical Market Research Report 2012-2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Objectives of Research
      • 1.1.1 Definition
      • 1.1.2 Specifications
    • 1.2 Market Segment
      • 1.2.1 by Type
        • 1.2.1.1 SPECT Radioisotopes
        • 1.2.1.2 PET Radioisotopes
        • 1.2.1.3 Other Diagnostic Radioisotopes
        • 1.2.1.4 Therapeutic Radioisotopes
      • 1.2.2 by Application
        • 1.2.2.1 Oncology
        • 1.2.2.2 Cardiology
        • 1.2.2.3 Others
      • 1.2.3 by Regions

    2 Industry Chain

    • 2.1 Industry Chain Structure
    • 2.2 Upstream
    • 2.3 Market
      • 2.3.1 SWOT
      • 2.3.2 Dynamics

    3 Environmental Analysis

    • 3.1 Policy
    • 3.2 Economic
    • 3.3 Technology
    • 3.4 Market Entry

    4 Market Segmentation by Type

    • 4.1 Market Size
      • 4.1.1 SPECT Radioisotopes Market, 2013-2018
      • 4.1.2 PET Radioisotopes Market, 2013-2018
      • 4.1.3 Other Diagnostic Radioisotopes Market, 2013-2018
      • 4.1.4 Therapeutic Radioisotopes Market, 2013-2018
    • 4.2 Market Forecast
      • 4.2.1 SPECT Radioisotopes Market Forecast, 2019-2024
      • 4.2.2 PET Radioisotopes Market Forecast, 2019-2024
      • 4.2.3 Other Diagnostic Radioisotopes Market Forecast, 2019-2024
      • 4.2.4 Therapeutic Radioisotopes Market Forecast, 2019-2024

    5 Market Segmentation by Application

    • 5.1 Market Size
      • 5.1.1 Oncology Market, 2013-2018
      • 5.1.2 Cardiology Market, 2013-2018
      • 5.1.3 Others Market, 2013-2018
    • 5.2 Market Forecast
      • 5.2.1 Oncology Market Forecast, 2019-2024
      • 5.2.2 Cardiology Market Forecast, 2019-2024
      • 5.2.3 Others Market Forecast, 2019-2024

    6 Market Segmentation by Region

    • 6.1 Market Size
      • 6.1.1 Asia-Pacific
        • 6.1.1.1 Asia-Pacific Market, 2012-2018
        • 6.1.1.2 Asia-Pacific Market by Type
        • 6.1.1.3 Asia-Pacific Market by Application
      • 6.1.2 North America
        • 6.1.2.1 North America Market, 2012-2018
        • 6.1.2.2 North America Market by Type
        • 6.1.2.3 North America Market by Application
      • 6.1.3 Europe
        • 6.1.3.1 Europe Market, 2012-2018
        • 6.1.3.2 Europe Market by Type
        • 6.1.3.3 Europe Market by Application
      • 6.1.4 South America
        • 6.1.4.1 South America Market, 2012-2018
        • 6.1.4.2 South America Market by Type
        • 6.1.4.3 South America Market by Application
      • 6.1.5 Middle East & Africa
        • 6.1.5.1 Middle East & Africa Market, 2012-2018
        • 6.1.5.2 Middle East & Africa Market by Type
        • 6.1.5.3 Middle East & Africa Market by Application
    • 6.2 Market Forecast
      • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
      • 6.2.2 North America Market Forecast, 2019-2024
      • 6.2.3 Europe Market Forecast, 2019-2024
      • 6.2.4 South America Market Forecast, 2019-2024
      • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

    7 Market Competitive

    • 7.1 Global Market by Vendors
    • 7.2 Market Concentration
    • 7.3 Price & Factors
    • 7.4 Marketing Channel

    8 Major Vendors

    • 8.1 Bayer
    • 8.2 Triad Isotopes
    • 8.3 Lantheus
    • 8.4 GE Healthcare
    • 8.5 Mallinckrodt
    • 8.6 Eli Lilly
    • 8.7 Bracco Imaging
    • 8.8 SIEMENS
    • 8.9 Navidea
    • 8.10 Nordion
    • 8.11 IBA Group
    • 8.12 Jubilant Pharma

    9 Conclusion

    Summary
    Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
    The global Radiopharmaceutical market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
    Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
    SPECT Radioisotopes
    PET Radioisotopes
    Other Diagnostic Radioisotopes
    Therapeutic Radioisotopes
    Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
    Bayer
    Triad Isotopes
    Lantheus
    GE Healthcare
    Mallinckrodt
    Eli Lilly
    Bracco Imaging
    SIEMENS
    Navidea
    Nordion
    IBA Group
    Jubilant Pharma
    Based on Application, the report describes major application share of regional market. Application mentioned as follows:
    Oncology
    Cardiology
    Others
    Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa

    Buy now